chrX-5892944-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_181332.3(NLGN4X):c.2324C>T(p.Thr775Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000661 in 1,209,514 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000064 ( 0 hom. 1 hem. )
Consequence
NLGN4X
NM_181332.3 missense
NM_181332.3 missense
Scores
2
8
7
Clinical Significance
Conservation
PhyloP100: 8.57
Genes affected
NLGN4X (HGNC:14287): (neuroligin 4 X-linked) This gene encodes a member of the type-B carboxylesterase/lipase protein family. The encoded protein belongs to a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. The encoded protein interacts with discs large homolog 4 (DLG4). Mutations in this gene have been associated with autism and Asperger syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLGN4X | NM_181332.3 | c.2324C>T | p.Thr775Met | missense_variant | 6/6 | ENST00000381095.8 | NP_851849.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLGN4X | ENST00000381095.8 | c.2324C>T | p.Thr775Met | missense_variant | 6/6 | 1 | NM_181332.3 | ENSP00000370485 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00000899 AC: 1AN: 111247Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33435
GnomAD3 genomes
AF:
AC:
1
AN:
111247
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33435
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183528Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67958
GnomAD3 exomes
AF:
AC:
1
AN:
183528
Hom.:
AF XY:
AC XY:
1
AN XY:
67958
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000637 AC: 7AN: 1098267Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 1AN XY: 363621
GnomAD4 exome
AF:
AC:
7
AN:
1098267
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
363621
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000899 AC: 1AN: 111247Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33435
GnomAD4 genome
AF:
AC:
1
AN:
111247
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33435
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 11, 2017 | The p.T775M variant (also known as c.2324C>T), located in coding exon 5 of the NLGN4X gene, results from a C to T substitution at nucleotide position 2324. The threonine at codon 775 is replaced by methionine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D;D;.;D
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;.;D;.
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;.;M
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;N;D;.;D
REVEL
Uncertain
Sift
Benign
T;D;T;.;T
Sift4G
Uncertain
D;D;D;.;D
Polyphen
D;D;D;D;D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at